Home›Trial›NCT05552755
🔬NCT05552755Phase 1Phase 2RECRUITING

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Study Summary

This is a multicenter, two-part trial in participants with FAP.

Conditions
Familial Adenomatous Polyposis
Interventions / Drugs
REC-4881Placebo
View on ClinicalTrials.gov ↗
Sponsor
RXRX
Recursion Pharmaceuticals
AI Drug Discovery
D38/100
Study Details
Enrollment67 participants
Primary Completion—
Lead SponsorRecursion Pharmaceuticals Inc.
Data Retrieved2026-04-11 04:26:31.746419+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.